loading page

Women and Atrial Fibrillation
  • +9
  • ANNABELLE VOLGMAN,
  • Emelia Benjamin,
  • Anne Curtis,
  • Margaret Fang,
  • Kathryn Lindley,
  • Gerald Naccarelli,
  • Carl Pepine,
  • Odayme Quesada,
  • Marmar Vaseghi,
  • Albert Waldo,
  • Nanette Wenger,
  • Andrea Russo
ANNABELLE VOLGMAN
Rush University Medical Center
Author Profile
Emelia Benjamin
Boston University
Author Profile
Anne Curtis
University at Buffalo
Author Profile
Margaret Fang
University of California San Francisco
Author Profile
Kathryn Lindley
Washington University in St Louis
Author Profile
Gerald Naccarelli
Penn State Heart and Vascular Institute
Author Profile
Carl Pepine
University of Florida College of Medicine
Author Profile
Odayme Quesada
Christ Hospital
Author Profile
Marmar Vaseghi
UCLA Cardiac Arrhythmia Center
Author Profile
Albert Waldo
Case Western Reserve University School of Medicine
Author Profile
Nanette Wenger
Emory University School of Medicine
Author Profile
Andrea Russo
Cooper University Hospital
Author Profile

Abstract

Atrial fibrillation (AF) remains a growing problem in the United States and worldwide, imposing a high individual and health system burden, including increased resource consumption due to repeated hospitalizations, stroke, dementia, heart failure, and death. This comprehensive review summarizes the most recent data on sex-related differences in risks associated with AF. Women with AF have increased risk of stroke and death compared to men, and possible reasons for this disparity are explored. Women also continue to have worse symptoms and quality of life, and poorer outcomes with stroke prevention, as well as with rate and rhythm control management strategies. Many current rhythm control treatment strategies for AF, including cardioversion and ablation, are used less frequently in women as compared to men, whereas women are more likely to be treated with rate control strategies or anti-arrhythmic drugs. Sex differences should be considered in treating women with AF to improve outcomes and women and men should be offered the same interventions for AF. We need to improve the evidence base to understand if variation in utilization of rate and rhythm control management between men and women represents health inequities or appropriate clinical judgement.

Peer review status:POSTED

30 Nov 2020Submitted to Journal of Cardiovascular Electrophysiology
02 Dec 2020Assigned to Editor
02 Dec 2020Submission Checks Completed